Acurx Pharmaceuticals Inc. (ACXP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Acurx Pharmaceuticals Inc...

    NASDAQ: ACXP · Real-Time Price · USD
    4.02
    -0.13 (-3.13%)
    At close: Sep 25, 2025, 3:59 PM
    4.07
    1.24%
    After-hours: Sep 25, 2025, 07:04 PM EDT

    Acurx Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -14.1M -14.58M -12.09M -12.81M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -14.1M -14.58M -12.09M -12.75M
    Net Income
    		 -14.1M -14.58M -12.09M -12.75M
    Selling & General & Admin
    		 8.7M 8.53M 7.34M 10.78M
    Research & Development
    		 5.4M 6.04M 4.75M 2.03M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 14.1M 14.58M 12.09M 12.81M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 14.1M 14.58M 12.09M 12.81M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 851.55K 633.6K 540.8K 510.8K
    Shares Outstanding (Diluted)
    		 851.55K 633.6K 540.8K 510.8K
    EPS (Basic)
    		 -17.59 -23.01 -22.36 -24.96
    EPS (Diluted)
    		 -17.59 -23.01 -22.36 -24.96
    EBITDA
    		 -14.1M -14.58M -12.09M -12.75M
    EBIT
    		 -14.1M -14.58M -12.09M -12.75M
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist